Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Colonna

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Bulletin Du Cancer|March 6, 2019
[Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence]Anne Cowppli-Bony, Marc Colonna, Karine Ligier, et al.
Breast (Edinburgh, Scotland)|May 31, 2016
Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based dataArnaud Seigneurin, José Labarère, Olivier François, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 23, 2016
Trends in net survival from pancreatic cancer in six European Latin countries: results from the SUDCAN population-based studyAnne-Marie Bouvier, Nadine Bossard, Marc Colonna, et al.
Biometrics|September 2, 2020
Modeling excess hazard with time-to-cure as a parameterOlayidé Boussari, Laurent Bordes, Gaëlle Romain, et al.
American Journal of Industrial Medicine|June 14, 2012
Cancer incidence in a chlorochemical plant in Isère, France: an occupational cohort study, 1979-2002Vincent Bonneterre, Gérard Mathern, Odile Pelen, et al.
European Journal of Epidemiology|July 20, 2007
Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge databaseZoe Uhry, Marc Colonna, Laurent Remontet, et al.
BMC Medical Research Methodology|March 25, 2023
A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life dataLaura Botta, Juste Goungounga, Riccardo Capocaccia, et al.
Anticancer Research|May 16, 2009
Kinetics of HER2/neu ECD in 45 patients treated with trastuzumab (Herceptin) between January 2001 and June 2005 at the Grenoble University HospitalAnne-Sophie Gauchez, Marc Colonna, François-Xavier Brand, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 7, 2005
Uncertainty and sensitivity analysis in assessment of the thyroid cancer risk related to Chernobyl fallout in Eastern FranceOlivier Catelinois, Dominique Laurier, Pierre Verger, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2013
Sensitivity of a colorectal cancer screening program based on a guaiac test: a population-based studyJoris Giai, Catherine Exbrayat, Bastien Boussat, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Bulletin Du Cancer|March 6, 2019
[Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence]Anne Cowppli-Bony, Marc Colonna, Karine Ligier, et al.
Breast (Edinburgh, Scotland)|May 31, 2016
Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based dataArnaud Seigneurin, José Labarère, Olivier François, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 23, 2016
Trends in net survival from pancreatic cancer in six European Latin countries: results from the SUDCAN population-based studyAnne-Marie Bouvier, Nadine Bossard, Marc Colonna, et al.
Biometrics|September 2, 2020
Modeling excess hazard with time-to-cure as a parameterOlayidé Boussari, Laurent Bordes, Gaëlle Romain, et al.
American Journal of Industrial Medicine|June 14, 2012
Cancer incidence in a chlorochemical plant in Isère, France: an occupational cohort study, 1979-2002Vincent Bonneterre, Gérard Mathern, Odile Pelen, et al.
European Journal of Epidemiology|July 20, 2007
Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge databaseZoe Uhry, Marc Colonna, Laurent Remontet, et al.
BMC Medical Research Methodology|March 25, 2023
A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life dataLaura Botta, Juste Goungounga, Riccardo Capocaccia, et al.
Anticancer Research|May 16, 2009
Kinetics of HER2/neu ECD in 45 patients treated with trastuzumab (Herceptin) between January 2001 and June 2005 at the Grenoble University HospitalAnne-Sophie Gauchez, Marc Colonna, François-Xavier Brand, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 7, 2005
Uncertainty and sensitivity analysis in assessment of the thyroid cancer risk related to Chernobyl fallout in Eastern FranceOlivier Catelinois, Dominique Laurier, Pierre Verger, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2013
Sensitivity of a colorectal cancer screening program based on a guaiac test: a population-based studyJoris Giai, Catherine Exbrayat, Bastien Boussat, et al.
Pageof 9